SITC 2016 Annual Meeting & Associated Programs
SITC 2016 Annual Meeting & Associated Programs

Society for Immunotherapy of Cancer (SITC)

2016 Annual Meeting & Associated Programs

Enduring Materials

Access slide decks and video via the links in the schedule below.

PDF = Click on presentation title to view .pdf version of slides

VIDEO = Presentation video is available; click on the icon to view 

Program Schedule

Thursday, November 10, 2016
 

8:00 a.m. – 8:05 a.m. Welcome & Introductions
Andrew Zloza, MD, PhD –  Rutgers Cancer Institute of New Jersey

Session I: Introduction to Models of Immunotherapy

2.0 AMA PRA Category 1 Credits™

8:05 a.m. – 8:35 a.m. Major Questions Related to Immunotherapies that Require Models to Address  PDF  VIDEO
Mario Sznol, MD – Yale School of Medicine
8:35 a.m. – 9:05 a.m. Overview of Mouse-Mouse Models  PDF  VIDEO
Marcus W. Bosenberg, MD, PhD – Yale School of Medicine
9:05 a.m. – 9:35 a.m. Overview of Humanized Mice Models  PDF  VIDEO
A. Karolina Palucka, MD, PhD – The Jackson Laboratory for Genomic Medicine
9:35 a.m. – 10:05 a.m. Overview of Patient-Derived Xenograft (PDX) Models  VIDEO
Andrew Zloza, MD, PhD – Rutgers Cancer Institute of New Jersey

Session II: Modeling the Tumor Microenvironment

2.0 AMA PRA Category 1 Credits™

10:35 a.m. – 11:05 a.m. Evaluation of the Tumor Microenvironment  PDF  VIDEO
Mark B. Headley, PhD – University of California San Francisco
11:05 a.m. – 11:35 a.m. Factors Affecting Tumor Microenvironment Interactions
Lisa M. Coussens, PhD – Oregon Health and Sciences University
11:35 a.m. – 12:05 p.m. Vascular Regulation of the Tumor Microenvironment and Immune Responses
Amanda Lund, PhD – Oregon Health & Science University
12:05 p.m. – 12:35 p.m. Components of the Tumor Microenvironment that Module Tumor Immune Responses
Kwok-Kin Wong, MD, PhD – Dana-Farber Cancer Institute, Harvard Medical School

Session III: Modeling Evaluation of Immune Therapies

1.75 AMA PRA Category 1 Credits™

1:25 p.m. – 2:00 p.m. Evaluation of Immune Checkpoint Inhibitors in Mice
Arlene H. Sharpe, MD, PhD – Harvard Medical School
2:00 p.m. – 2:35 p.m. Reevaluating the Role of IDO1 in Brain Cancer; Humanized Immunocompetent Mice Take Center Stage
Derek A. Wainwright, PhD – Northwestern University
2:35 p.m. – 3:10 p.m. Developing New Immunotherapies in Preclinical Models and Humans  PDF  VIDEO
Elizabeth M. Jaffee, MD – The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
3:10 p.m. – 3:45 p.m. What Information Provided by Models will Inform Immune Drug Development and Use?  PDF  VIDEO
Philip Gotwals, PhD – Novartis Institutes for BioMedical Research, Inc.

Session IV: Panel Discussion and Future Directions
 

4:05 p.m. – 4:45 p.m. Future Directions for the Development and Use of Cancer Immune Models
Panelists:
Lisa M. Coussens, PhD – Oregon Health and Sciences University
Philip Gotwals, PhD – Novartis Institutes for BioMedical Research, Inc.
Elizabeth M. Jaffee, MD – The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University  
A. Karolina Palucka, MD, PhD – The Jackson Laboratory for Genomic Medicine
Arlene H. Sharpe, PhD – Harvard Medical School
Mario Sznol, MD – Yale School of Medicine
Kwok-Kin Wong, MD, PhD – Dana-Farber Cancer Institute, Harvard Medical School
Andrew Zloza, MD, PhD – Rutgers Cancer Institute of New Jersey
4:45 p.m. – 5:00 p.m. Closing Remarks
Marcus W. Bosenberg, MD, PhD – Yale School of Medicine
 
2016 Annual Meeting
2016 Annual Meeting
2016 Annual Meeting
2016 Annual Meeting
2016 Annual Meeting

Important Dates

Thank You, Supporters!

Thank you, SITC 2016 supporters. Because of your generosity, SITC 2016 was a great success!

Interested in supporting other SITC programs? Confirm your support today!

Connect with SITC!

SITC: Join Today

SITC: TWITTERSITC: LINKEDINSITC: YOUTUBESITC: ONCOLOGY TUBE